A detailed history of Kempen Capital Management N.V. transactions in Amgen Inc stock. As of the latest transaction made, Kempen Capital Management N.V. holds 72,503 shares of AMGN stock, worth $22.5 Million. This represents 0.26% of its overall portfolio holdings.

Number of Shares
72,503
Previous 74,792 3.06%
Holding current value
$22.5 Million
Previous $21.5 Million 4.3%
% of portfolio
0.26%
Previous 0.3%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

SELL
$268.87 - $324.56 $615,443 - $742,917
-2,289 Reduced 3.06%
72,503 $20.6 Million
Q4 2023

Feb 14, 2024

BUY
$255.7 - $288.46 $19.1 Million - $21.6 Million
74,792 New
74,792 $21.5 Million
Q4 2021

Feb 11, 2022

SELL
$198.88 - $227.6 $1.21 Million - $1.39 Million
-6,101 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$212.27 - $248.7 $19,953 - $23,377
94 Added 1.56%
6,101 $1.3 Million
Q2 2021

Aug 13, 2021

SELL
$233.58 - $259.14 $92,030 - $102,101
-394 Reduced 6.16%
6,007 $1.46 Million
Q1 2021

May 14, 2021

BUY
$221.91 - $258.6 $140,247 - $163,435
632 Added 10.96%
6,401 $1.59 Million
Q4 2020

Feb 12, 2021

SELL
$216.38 - $257.67 $198,853 - $236,798
-919 Reduced 13.74%
5,769 $1.33 Million
Q3 2020

Nov 10, 2020

BUY
$234.65 - $260.95 $32,381 - $36,011
138 Added 2.11%
6,688 $1.7 Million
Q2 2020

Aug 14, 2020

BUY
$197.81 - $242.74 $198,799 - $243,953
1,005 Added 18.12%
6,550 $1.55 Million
Q1 2020

May 15, 2020

BUY
$182.24 - $241.7 $10,205 - $13,535
56 Added 1.02%
5,545 $1.12 Million
Q4 2019

Feb 14, 2020

SELL
$189.21 - $243.2 $341,902 - $439,462
-1,807 Reduced 24.77%
5,489 $1.32 Million
Q3 2019

Nov 14, 2019

SELL
$174.11 - $208.62 $355,880 - $426,419
-2,044 Reduced 21.88%
7,296 $1.41 Million
Q2 2019

Aug 14, 2019

BUY
$166.7 - $195.41 $623,458 - $730,833
3,740 Added 66.79%
9,340 $1.72 Million
Q1 2019

May 15, 2019

BUY
$180.87 - $203.88 $1.01 Million - $1.14 Million
5,600 New
5,600 $1.06 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $166B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Kempen Capital Management N.V. Portfolio

Follow Kempen Capital Management N.V. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kempen Capital Management N.V., based on Form 13F filings with the SEC.

News

Stay updated on Kempen Capital Management N.V. with notifications on news.